[Funding alert] Fullife Healthcare raises $22M from Morgan Stanley Private Equity Asia

Rakesh Jhunjhunwala-supported wellbeing and nourishment organization Fullife Healthcare raised Series C financing of $22 million by Morgan Stanley Private Equity Asia (MSPEA), the organization said on Monday.


The organization sells dynamic nourishment and magnificence items through its lead brands Fast&Up and Chicnutrix separately.


"An enormous piece of the subsidizing will go into building our brands in India, expanding our essence, our item portfolio, our classes that we play, and obviously, center around the innovation," said Varun Khanna, CEO of Fullife Healthcare, while addressing YourStory.

An expanding number of Indians are deciding to purchase action and health supplements, which is helping the organization's development base. "It is just a hint of something larger, there's a gigantic excursion to go," he added. The market will develop as they pick dynamic and better ways of life.

Fullife makers medical services and nutraceutical items utilizing bubbly innovation. Its securing of Switzerland-based Novelty Pharma helped drive its development in this vertical.

The organization is a retrogressive incorporated organization with its own R&D focus just as assembling plants, and works on an omnichannel dissemination model. For both of its brands, it does its own turn of events, producing, in-house quality evaluations, on the web, and disconnected dispersion to the buyer.


"Fabricating is a vital part for us. We would rather not get into the matter of foolishness," said Khanna.


"Raising $22 million from Morgan Stanley is verification that you don't have to think twice about quality. You don't have to compromise," said Varun.


"Being a fruitful business person in India, it's really about taking a gander at how the clients benefit from the item," he added.

The organization, which sells its brands in better places in Europe, America other than India, adheres to European quality guidelines, which are more rigid than Indian norms.

"We need to construct a brand which fits for a really long time," he added.


This implies putting resources into assembling limit, increasing the current resources and innovation to build up its position. The organization is zeroing in on adding more useful materials and another conveyance design.


With regards to new classifications, Varun feels their quality external India would assist them with measuring the pattern and carry it to India.


Its 'Fast&Up' image, which conveys dynamic living nourishment and invulnerability, is now present in India, Italy. The organization began venturing into other European and American nations in 2018.

Fullife dispatched Chicnutrix in 2019. The all-ladies' health, excellence and sustenance brand is available in six nations and sells eight items under its portfolio — going from skincare, haircare, nails, PCOS, and UTI items.


Fullife additionally makes and products for other private names.


Established in 2011, Fullife is additionally supported by financial backers like Rakesh Jhunjhunwala, Sixth Sense Ventures, Kotak Securities, and Akash Prakash.


"MSPEA is extremely eager to put into Fullife, which is cutting a specialty in the trendy nourishment, dynamic way of life and health space through its novel bubbly and plant-based contributions," said Nirav Mehta, Managing Director, MSPEA, adding, "Fullife's key brands Fast&Up and Chicnutrix are now commonly recognized names, and the organization is all around situated to arise as a main worldwide player in the space, upheld by its wide item portfolio, in-house producing capacities, worldwide business impression and omnichannel dispersion."


If you want us to take your startup from idea phase to successful funding reach out to us.


Latest funding News

Bengaluru-based electric bike startup Ultraviolette Automotive Pvt Ltd has allegedly raised $14.85 million or Rs 112.5 crore from TVS Motor and Zoho Corporation in a Series C round, as indicated by a MCA recording dated December 8, 2021.

Biotech organization Zumutor Biologics has brought $6.2 million up in Series A4 subsidizing.

Hyderabad-based dialysis specialist co-op, Nephroplus, on Monday has brought $24 million up in Series E round to seek after development openings across India and select International business sectors.